Divergence in Aerobic Capacity Drives Liver and Brain Health

有氧能力的差异促进肝脏和大脑健康

基本信息

  • 批准号:
    10286535
  • 负责人:
  • 金额:
    $ 37.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Project Abstract/Summary Alzheimer’s Disease (AD) is the most common form of dementia evoking a terrible personal and financial toll. Most AD cases are sporadic with no known direct genetic cause. Several factors associate strongly with AD risk including metabolic disease states of two diabetes (T2D) and more recently fatty liver disease. A physical trait, aerobic capacity, the maximal capacity to use oxygen during exercise, has been independently linked to increased risk for T2D, fatty liver, and AD. How intrinsic aerobic capacity impacts disease independent of daily activity or exercise remains relatively unknown. We use rats selectively bred for divergence in intrinsic aerobic capacity to reveal mechanisms. Two-way artificial selective breeding created high and low capacity runner (HCR/LCR) rat strains divergent for intrinsic aerobic capacity. HCR/LCR rats are not exposed to exercise and display a contrasting, 40% difference in intrinsic aerobic capacity in a sedentary condition. LCR are highly susceptible to high fat diet (HFD)-induced obesity, hepatic steatosis, insulin resistance, neurodegeneration, and a shorter lifespan (4-6 months). In contrast, the HCR are resistant to HFD induced steatosis, insulin resistance and obesity. This polygenetic model more accurately reflects the impact of intrinsic aerobic capacity on human health and mortality, and better represents the protection or susceptibility for clinical development of many chronic diseases such as T2D, hepatic steatosis, and AD compared to other animal models. Our parent grant (R01DK121497) investigates intrinsic aerobic capacity and exercise in mediating the risk of hepatic steatosis through liver mitochondrial function/bile acid synthesis and epigenetic/proteomic modulations. We recently examined brain samples from HCR/LCR rats and found increased phosphorylated tau, amyloid beta (Aβ) (both are AD pathological hallmarks) and altered mitochondrial function. Importantly, HCR/LCR rats are not transgenic models of AD; but a polygenetic model which more faithfully represents the clinical links between aerobic capacity, exercise, and chronic disease. We propose to examine the brains from HCR/LCR rats and sedentary/exercised mice fed a HFD in conjunction with the parent R01. We will also examine the effects of liver derived excretions (metabolites, hormones, proteins) on neuronal and glial cell health and function. We will have the ability to correlate liver health, systemic anthropometrics, and aerobic capacity. The work proposed here is a natural extension of our ongoing research and will further the AD field by establishing mechanistic links between aerobic capacity, liver health, and AD. The experiments we now propose are well- within the scope of NOT-AG-20-034.
项目摘要/总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John P Thyfault其他文献

John P Thyfault的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John P Thyfault', 18)}}的其他基金

Kansas Center for Metabolism and Obesity REsearch (KC-MORE)
堪萨斯代谢和肥胖研究中心 (KC-MORE)
  • 批准号:
    10725916
  • 财政年份:
    2022
  • 资助金额:
    $ 37.76万
  • 项目类别:
Kansas Center for Metabolism and Obesity REsearch (KC-MORE)
堪萨斯代谢和肥胖研究中心 (KC-MORE)
  • 批准号:
    10598012
  • 财政年份:
    2022
  • 资助金额:
    $ 37.76万
  • 项目类别:
Kansas Center for Metabolism and Obesity REsearch (KC-MORE)
堪萨斯代谢和肥胖研究中心 (KC-MORE)
  • 批准号:
    10799329
  • 财政年份:
    2022
  • 资助金额:
    $ 37.76万
  • 项目类别:
Translating Obesity, Metabolic Dysfunction and Comorbid Disease States
转化肥胖、代谢功能障碍和共存疾病状态
  • 批准号:
    10411630
  • 财政年份:
    2022
  • 资助金额:
    $ 37.76万
  • 项目类别:
Translating Obesity, Metabolic Dysfunction and Comorbid Disease States
转化肥胖、代谢功能障碍和共存疾病状态
  • 批准号:
    10623307
  • 财政年份:
    2022
  • 资助金额:
    $ 37.76万
  • 项目类别:
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
有氧健身、线粒体功能和脂肪肝。
  • 批准号:
    10205054
  • 财政年份:
    2019
  • 资助金额:
    $ 37.76万
  • 项目类别:
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
有氧健身、线粒体功能和脂肪肝。
  • 批准号:
    10442514
  • 财政年份:
    2019
  • 资助金额:
    $ 37.76万
  • 项目类别:
Skeletal muscle mitochondrial abnormalities in Alzheimer's Disease
阿尔茨海默病中的骨骼肌线粒体异常
  • 批准号:
    9474088
  • 财政年份:
    2017
  • 资助金额:
    $ 37.76万
  • 项目类别:
Skeletal muscle mitochondrial abnormalities in Alzheimer's Disease
阿尔茨海默病中的骨骼肌线粒体异常
  • 批准号:
    9322823
  • 财政年份:
    2017
  • 资助金额:
    $ 37.76万
  • 项目类别:
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosis
性别二态性、肝线粒体适应和肝脂肪变性
  • 批准号:
    9891404
  • 财政年份:
    2014
  • 资助金额:
    $ 37.76万
  • 项目类别:

相似海外基金

Developing Late Metal Catalytic Systems for Aerobic Partial Oxidation of Alkanes
开发烷烃有氧部分氧化的后金属催化系统
  • 批准号:
    2247667
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
    Standard Grant
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
  • 批准号:
    23K07830
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses
阿尔茨海默病的精准医学:使用 AT(N) 生物标志物优化有氧健身反应的适应性运动及其作用机制的 SMART 试验
  • 批准号:
    10581973
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
  • 批准号:
    10585366
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
  • 批准号:
    10696409
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
Investigating the physical and chemical controls on aerobic methane oxidation
研究好氧甲烷氧化的物理和化学控制
  • 批准号:
    2241873
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
    Standard Grant
Effect of aerobic exercise-induced sleep changes on arterial stiffness associated with postprandial hyperglycemia.
有氧运动引起的睡眠变化对与餐后高血糖相关的动脉僵硬度的影响。
  • 批准号:
    23K10645
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除;
  • 批准号:
    485524
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
    Operating Grants
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
  • 批准号:
    10717825
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
The Effects of Aerobic Exercise on Cardiovascular Health in Postmenopausal Females: A Systematic Review and Meta-Analysis
有氧运动对绝经后女性心血管健康的影响:系统评价和荟萃分析
  • 批准号:
    480729
  • 财政年份:
    2023
  • 资助金额:
    $ 37.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了